SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SciClone Pharmaceuticals (Holdings) Limited has issued an update revealing the exercise of 207,900 Share Options under its Post-IPO Option Plan, resulting in the issuance of an equivalent number of new shares. This exercise brings the total number of shares in the company to 630,543,012, with a remaining 66,231,052 Share Options still outstanding. This announcement is part of the process for the proposed company privatisation by Silver Pegasus Investment Limited.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.